Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory ...

Shares of Moderna Inc. MRNA inched 0.92% higher to $42.57 Monday, on what proved to be an all-around mixed trading session ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Moderna is a contrarian play for 2025, despite a rough 2024 as one of the worst-performing Nasdaq-100 stocks. Click here to ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

The Centers for Disease Control and Prevention is currently monitoring reports of a spike in human metapneumovirus (HMPV) in ...

Moderna's (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off. Despite what it seems, though, Moderna has ...

Moderna ( MRNA) was the best-performing stock in the S&P 500 as Barron's called it "too cheap" and named the biotech firm as ...

The strain is spreading among US dairy cows, and has infected dozens of people, mainly US farmworkers. Read more at ...

We recently published a list of 10 Firms End 2024 Stronger With Impressive Gains. In this article, we are going to take a ...